RIGVIR SE
Biologically active food supplement
✅ Intended for a weakened immune system
✅ For smart people with an increased risk of cancer
✅ Enhances the effectiveness of cancer immunotherapy
✅ Development is based of scientific and clinical trials
✅ Take only one capsule per month
✅ Third party tested
125 EUR
The Synergistic Power of Rigvir SE
The ability to selectively identify and target cancer cells
Stimulates the body’s immune defense by activating anti-tumor immunity
Contains Non-toxic, Non-genetically modified, and Non-pathogenic ECHO-7 virus Rigvir wich is specially adapted for various cancer cell recognition
Rigvir SE’s active ingredient, the ECHO-7 virus Rigvir, is internationally patented and has been helping people around the world for over 20 years
Immune Booster – Natural Killer Cell Activator
Smart immune activation not only supports overall well-being and increased performance, but also strengthens the body’s defenses against various illnesses, including cancer.
Rigvir SE supports a rapid rise in leukocytes, neutrophils, and lymphocytes. Over time, it has been shown to positively influence key immune components including CD4+ and CD8+ T cells, B lymphocytes, natural killer (NK) cells, and important immunoglobulins like IgA, IgG, and IgM.
Give your immune system the care it deserves — strengthen it with Rigvir SE just once a month.
"With Rigvir SE you have the opportunity to stay one step ahead of medicine and help your body reduce cancer risks now."
Prof. Ivars Kalvins
Scientist and Smart Nanovirus Limited Co-Founder
He is the author of over 500 publications and patent applications, was nominated as a finalist for the European Inventor Award 2015 in the Lifetime Achievement category, and has been awarded the WIPO Golden Medal.
Watch a Brief History of
Oncolytic Virus Rigvir
Scientifically proven trustworthiness
Rigvir SE has completed several studies, including the ones related to virus long term stability.
The development of Rigvir SE is based on science, medicine and long-term pre-clinical and clinical practice since the 1960s.
Rigvir SE ingredient virus Rigvir medicine form has been registered in 2004 for treatment of various cancer types and prevention of metastasis.
The amount virus in Rigvir SE is smaller than the one used in the production of the Rigvir medicine.
Who is Rigvir SE intended for?
Rigvir SE is intended for individuals with a weakened immune system or an increased risk of developing cancer. This includes those with a genetic predisposition, elevated tumour markers, age over 65, AI-based cancer risk assessments, or precancerous conditions such as mycoplasmosis, toxoplasmosis, human papillomavirus (HPV), chronic obstructive pulmonary disease (COPD), Helicobacter pylori infection, polyps, Crohn’s disease, ulcerative colitis, diabetes, and more. It is also recommended for individuals taking medications known to increase cancer risk.
Take only one capsule per month
One Rigvir SE capsule per month with one glass of water in the morning on an empty stomach. If needed, the dose may be increased based on recommendations from a healthcare professional.
According to healthcare professionals’ recommendations, Rigvir SE should be taken for at least 3 consecutive months, 3 capsules in total.
Effect of the Capsule
Rigvir SE ingredients are included in a capsule with special coating (hydroxypropyl methylcellulose) that allows it to cross the stomach and reach the intestine which is the most suitable environment for the Rigvir virus to provide its maximum benefit.
It is important to observe temperature regimen in the storage and during transportation of Rigvir SE.
Our Values
Safety – no side effects
Rigvir SE has completed the necessary tests, including safety, toxicology and sterility.
The ingredients have been separately tested for many years. Virus Rigvir is not-toxic, non-pathogenic and non-genetically modified; its harmlessness has been proved in long-term clinical practice and pre-clinical trials even with a multiple times greater dose compared to the one in Rigvir SE, ensuring an excellent safety and tolerance profile.
Quality – third party tested
Rigvir SE quality is checked on several levels:
- during production;
- while it is on the market;
- during storage in partner warehouses to ensure the required storage and monitoring conditions.
Independent third-party laboratories perform regular random Rigvir SE sample selection for sterility and stability testing.
Note. Smart Nanovirus Limited created a counterfeit surveillance system that allows us to identify possible Rigvir SE counterfeits quickly and easily.
Friendly Production
Production of Rigvir SE is a biotechnologically complicated, yet environmentally friendly process – without harmful waste and emissions.
Rigvir SE is manufactured in the European Union in GMP facilities according to the best pharmacy practices.
